期刊文献+

单纯性肥胖儿童黑色棘皮症与胰岛素抵抗性及细胞因子的关系 被引量:4

Association of acanthosis nigricans with insulin resistance and adipocytokine in children with simple obese
下载PDF
导出
摘要 目的 探讨单纯性肥胖儿童的黑色棘皮症(AN)和体质量指数、胰岛素抵抗性、瘦素、血浆酶原纤维蛋白溶解原活化抑制剂(PAI-1)的关系。方法 单纯性肥胖儿童38例,其中AN阳性17例,测量身高、体质量、腹围、臀围,同时测血胰岛素、瘦素、空腹血糖、PAI-1。结果 AN阳性者肥胖度、腹围、空腹胰岛素、自动动态平衡标准评价胰岛素抵抗指数(HOMA-R)关系有显著差异,AN与体脂肪率间无关。AN阳性肥胖儿中均升高,PAI-1 40μg/L以上,瘦素30 μg/L以上者均为AN阳性。结论 单纯性肥胖儿童,特别是伴AN阳性肥胖儿,要特别注意随访观察2型糖尿病和冠状动脉疾病的发生和发展。 Objective To determine the association of acanthosis nigricans(AN) with values for estimating insulin resistance and adipocytokine levels in simple obese children. Methods These subjects concluded 38 simple obese children. AN was present in 17 of 38 children. Height, weight and abdominal circumference were recorded and fasting blood sample was obtained for measurement of blood glucose, plasma insulin, leptin, and plasminogen activator inhibitor 1 (PAI-1) levels which were known as the risk factors of cardiovascular disease. We obtained homeostasis model assessment insulin resistance index (HOMA-R) by fasting blood glucose and plasma insulin levels. Results The severity of obesity, abdominal circumference, fasting insulin levels and HOMA-R were significantly higher in obese children to AN compared to those without AN. There was the tendency that children with AN had higher levels of leptin and PAI-1 compared to children without AN. Conclusions These results suggest that obese children with AN may have a risk of cardiovascular disease as well as type 2 diabetes mellitus.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2004年第10期851-853,共3页 Journal of Applied Clinical Pediatrics
关键词 肥胖 黑色棘皮症 2型糖尿病 瘦素 血浆酶原纤维蛋白溶解原活化抑制剂 obese acanthosis nigricans type 2 diabetes mellitus leptin plasminogen activator inhibitor 1
  • 相关文献

参考文献11

  • 1Ikezaki A, Miura N, Kikuoka N, et al. Clinical characteristics of obese Japanese children with acanthosis nigricans[J ]. Clin Pediatr Endocrinol, 2001,10: 47 - 52.
  • 2Huber K, Christ G, Wojta J, et al. Plasminogen activator inhibitor type- 1 in cardiovascular disease[J ]. Thromb Res, 2001, 103: 7 -19.
  • 3Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man[ J ]. Diabetologia, 1985,28:412-419.
  • 4儿玉浩子 洼田和兴.胰岛素受体异常症[J].小儿内科,1996,28:473-476.
  • 5西部泰弘 高松由佳 森俊典.胰岛素异常症C型合并黑色素肿一例[J].皮肤科临床,1999,41:1249-1251.
  • 6Rosenbaum M, Nicolson M, Hirsch J, et al. Effcts of gender, body composition, and menopause on plasma concentrations of leptin[J].J Clin Endocrinol Metab, 1996,81 (9): 3424 - 3427.
  • 7海津嘉藏 高木一郎.PAI—1[J].肾和透析,1997,(1):412-413.
  • 8Juhan-Vegue I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor-1 levels. A possible link between insulin resistance and atherothrombosis[ J ]. Diabetologia, 1991,34: 457 - 462.
  • 9Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity[ J ]. Nat Med, 1996,2:800 - 803.
  • 10Giltay EJ, Elbers JM, Gooren LJ, et al. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration[J ].Arterioscler Thromb Vasc Biol, 1998,18:1716 - 1722.

同被引文献63

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部